miR-205 in situ expression and localization in head and neck tumors - A tissue array study

Nurul Syakima Ab Mutalib, Lee Learn-Han, Cheah Yoke-Kqueen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: microRNAs are small non-coding RNA that control gene expression by mRNA degradation or translational inhibition. These molecules are known to play essential roles in many biological and physiological processes. miR-205 may be differentially expressed in head and neck cancers; however, there are conflicting data and localization of expression has yet to be determined. Materials and Methods: miR-205 expression was investigated in 48 cases of inflammatory, benign and malignant tumor tissue array of the neck, oronasopharynx, larynx and salivary glands by Locked Nucleic Acid in situ hybridization (LNA-ISH) technology. Results: miR-205 expression was significantly differentially expressed across all of the inflammatory, benign and malignant tumor tissues of the neck. A significant increase in miR-205 staining intensity (p<0.05) was observed from inflammation to benign and malignant tumors in head and neck tissue array, suggesting that miR-205 could be a biomarker to differentiate between cancer and non-cancer tissues. Conclusions: LNA-ISH revealed that miR-205 exhibited significant differential cytoplasmic and nuclear staining among inflammation, benign and malignant tumors of head and neck. miR-205 was not only exclusively expressed in squamous epithelial malignancy. This study offers information and a basis for a comprehensive study of the role of miR-205 that may be useful as a biomarker and/or therapeutic target in head and neck tumors.

Original languageEnglish
Pages (from-to)9071-9075
Number of pages5
JournalAsian Pacific Journal of Cancer Prevention
Volume15
Issue number21
DOIs
Publication statusPublished - 2014

Fingerprint

Neck
Head
Neoplasms
In Situ Hybridization
Biomarkers
Staining and Labeling
Physiological Phenomena
Inflammation
Biological Phenomena
Small Untranslated RNA
RNA Stability
Head and Neck Neoplasms
Larynx
Salivary Glands
MicroRNAs
Technology
Gene Expression
locked nucleic acid

Keywords

  • FFPE
  • Head and neck cancers
  • In situ hybridization
  • Locked nucleic acid
  • miR-205
  • Tumor tissue array

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

miR-205 in situ expression and localization in head and neck tumors - A tissue array study. / Ab Mutalib, Nurul Syakima; Learn-Han, Lee; Yoke-Kqueen, Cheah.

In: Asian Pacific Journal of Cancer Prevention, Vol. 15, No. 21, 2014, p. 9071-9075.

Research output: Contribution to journalArticle

@article{278a74d1c9804ed9b07a42aed7b015c9,
title = "miR-205 in situ expression and localization in head and neck tumors - A tissue array study",
abstract = "Background: microRNAs are small non-coding RNA that control gene expression by mRNA degradation or translational inhibition. These molecules are known to play essential roles in many biological and physiological processes. miR-205 may be differentially expressed in head and neck cancers; however, there are conflicting data and localization of expression has yet to be determined. Materials and Methods: miR-205 expression was investigated in 48 cases of inflammatory, benign and malignant tumor tissue array of the neck, oronasopharynx, larynx and salivary glands by Locked Nucleic Acid in situ hybridization (LNA-ISH) technology. Results: miR-205 expression was significantly differentially expressed across all of the inflammatory, benign and malignant tumor tissues of the neck. A significant increase in miR-205 staining intensity (p<0.05) was observed from inflammation to benign and malignant tumors in head and neck tissue array, suggesting that miR-205 could be a biomarker to differentiate between cancer and non-cancer tissues. Conclusions: LNA-ISH revealed that miR-205 exhibited significant differential cytoplasmic and nuclear staining among inflammation, benign and malignant tumors of head and neck. miR-205 was not only exclusively expressed in squamous epithelial malignancy. This study offers information and a basis for a comprehensive study of the role of miR-205 that may be useful as a biomarker and/or therapeutic target in head and neck tumors.",
keywords = "FFPE, Head and neck cancers, In situ hybridization, Locked nucleic acid, miR-205, Tumor tissue array",
author = "{Ab Mutalib}, {Nurul Syakima} and Lee Learn-Han and Cheah Yoke-Kqueen",
year = "2014",
doi = "10.7314/APJCP.2014.15.21.9071",
language = "English",
volume = "15",
pages = "9071--9075",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "21",

}

TY - JOUR

T1 - miR-205 in situ expression and localization in head and neck tumors - A tissue array study

AU - Ab Mutalib, Nurul Syakima

AU - Learn-Han, Lee

AU - Yoke-Kqueen, Cheah

PY - 2014

Y1 - 2014

N2 - Background: microRNAs are small non-coding RNA that control gene expression by mRNA degradation or translational inhibition. These molecules are known to play essential roles in many biological and physiological processes. miR-205 may be differentially expressed in head and neck cancers; however, there are conflicting data and localization of expression has yet to be determined. Materials and Methods: miR-205 expression was investigated in 48 cases of inflammatory, benign and malignant tumor tissue array of the neck, oronasopharynx, larynx and salivary glands by Locked Nucleic Acid in situ hybridization (LNA-ISH) technology. Results: miR-205 expression was significantly differentially expressed across all of the inflammatory, benign and malignant tumor tissues of the neck. A significant increase in miR-205 staining intensity (p<0.05) was observed from inflammation to benign and malignant tumors in head and neck tissue array, suggesting that miR-205 could be a biomarker to differentiate between cancer and non-cancer tissues. Conclusions: LNA-ISH revealed that miR-205 exhibited significant differential cytoplasmic and nuclear staining among inflammation, benign and malignant tumors of head and neck. miR-205 was not only exclusively expressed in squamous epithelial malignancy. This study offers information and a basis for a comprehensive study of the role of miR-205 that may be useful as a biomarker and/or therapeutic target in head and neck tumors.

AB - Background: microRNAs are small non-coding RNA that control gene expression by mRNA degradation or translational inhibition. These molecules are known to play essential roles in many biological and physiological processes. miR-205 may be differentially expressed in head and neck cancers; however, there are conflicting data and localization of expression has yet to be determined. Materials and Methods: miR-205 expression was investigated in 48 cases of inflammatory, benign and malignant tumor tissue array of the neck, oronasopharynx, larynx and salivary glands by Locked Nucleic Acid in situ hybridization (LNA-ISH) technology. Results: miR-205 expression was significantly differentially expressed across all of the inflammatory, benign and malignant tumor tissues of the neck. A significant increase in miR-205 staining intensity (p<0.05) was observed from inflammation to benign and malignant tumors in head and neck tissue array, suggesting that miR-205 could be a biomarker to differentiate between cancer and non-cancer tissues. Conclusions: LNA-ISH revealed that miR-205 exhibited significant differential cytoplasmic and nuclear staining among inflammation, benign and malignant tumors of head and neck. miR-205 was not only exclusively expressed in squamous epithelial malignancy. This study offers information and a basis for a comprehensive study of the role of miR-205 that may be useful as a biomarker and/or therapeutic target in head and neck tumors.

KW - FFPE

KW - Head and neck cancers

KW - In situ hybridization

KW - Locked nucleic acid

KW - miR-205

KW - Tumor tissue array

UR - http://www.scopus.com/inward/record.url?scp=84918577305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918577305&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2014.15.21.9071

DO - 10.7314/APJCP.2014.15.21.9071

M3 - Article

C2 - 25422181

AN - SCOPUS:84918577305

VL - 15

SP - 9071

EP - 9075

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 21

ER -